← Leaderboards
Owen T. Carmichael
Lsu Pennington Biomedical Research Ctr
$17,005,105
Attributed
$36,432,068
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.2M · FY2008–25$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,432,068 · 9
By mechanism
R01$29,733,904 · 6
RF1$4,202,675 · 1
S10$2,000,000 · 1
K01$495,489 · 1
Top collaborators
- Lydia Bazzano17 shared
- Robert Lee Newton11 shared
- Bret H. Goodpaster7 shared
- Tanika Nicole Kelly4 shared
- Elaine Mott Urbina3 shared
- Sarah Elizabeth Henson1 shared
Most similar at Lsu Pennington Biomedical Research Ctr
Same institution · by research overlap
- Eric Ravussin$38,240,488
- Tuomo Rankinen$8,501,295
- Robert Lee Newton$9,920,183
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposElderlyImpaired CognitionAdultS DiseaseBrainRisk FactorsParticipantBiologicalPhysical ActivityCognitiveProgramsStructurePrevalenceCohortCerebrumUnited States National Institutes Of HealthMiddle AgeMagnetic Resonance ImagingAgingExercisePathway InteractionsAmyloidPrevent
Grant awards (41)
I3C DECADE: Disparities and Equity in Childhood Cardiovascular Exposures and Alzheimer's Dementia$2,904,184
R01 · FY2025 · AG
Upgrade of 3T MRI system to Siemens Vida for metabolism-related human biomedical research$2,000,000
S10 · FY2025 · OD · contact PI
Reducing African Americans' Alzheimer's Disease Risk Through Exercise-MCI Cohort (RAATE-MCI)$884,785
R01 · FY2025 · AG
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)$705,457
R01 · FY2025 · AG
Early Life Cardiovascular Disease Risk Factors, Epigenetic Age Acceleration, and Alzheimer's Disease Related Brain Health$694,435
R01 · FY2025 · AG
I3C DECADE: Disparities and Equity in Childhood Cardiovascular Exposures and Alzheimer's Dementia$3,041,642
R01 · FY2024 · AG
Reducing African Americans' Alzheimer's Disease Risk Through Exercise-MCI Cohort (RAATE-MCI)$935,236
R01 · FY2024 · AG
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)$719,854
R01 · FY2024 · AG
Early Life Cardiovascular Disease Risk Factors, Epigenetic Age Acceleration, and Alzheimer's Disease Related Brain Health$708,607
R01 · FY2024 · AG
I3C DECADE: Disparities and Equity in Childhood Cardiovascular Exposures and Alzheimer's Dementia$3,051,224
R01 · FY2023 · AG
Reducing African Americans' Alzheimer's Disease Risk Through Exercise-MCI Cohort (RAATE-MCI)$934,561
R01 · FY2023 · AG
Early Life Cardiovascular Disease Risk Factors, Epigenetic Age Acceleration, and Alzheimer's Disease Related Brain Health$708,607
R01 · FY2023 · AG
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study$692,710
R01 · FY2023 · AG
Aging and the mitochondrial response to exercise training, measured by noninvasive 31P magnetic resonance spectroscopy$605,350
R01 · FY2023 · AG · contact PI
I3C DECADE: Disparities and Equity in Childhood Cardiovascular Exposures and Alzheimer's Dementia$2,891,965
R01 · FY2022 · AG
Early Life Cardiovascular Disease Risk Factors, Epigenetic Age Acceleration, and Alzheimer's Disease Related Brain Health$751,377
R01 · FY2022 · AG
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study$694,721
R01 · FY2022 · AG
Aging and the mitochondrial response to exercise training, measured by noninvasive 31P magnetic resonance spectroscopy$610,478
R01 · FY2022 · AG · contact PI
Lifespan Cardiovascular Risk Exposures and Alzheimer-related brain health: Bogalusa Heart Study$233,466
RF1 · FY2022 · AG
Aging and the mitochondrial response to exercise training, measured by noninvasive 31P magnetic resonance spectroscopy - sIRB supplement$22,106
R01 · FY2022 · AG · contact PI
Reducing African Americans' Alzheimer's Disease Risk Through Exercise-MCI Cohort (RAATE-MCI)$934,561
R01 · FY2021 · AG
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)$719,854
R01 · FY2021 · AG
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study$714,363
R01 · FY2021 · AG
Aging and the mitochondrial response to exercise training, measured by noninvasive 31P magnetic resonance spectroscopy$599,354
R01 · FY2021 · AG · contact PI
RAATE COVID Supplement$320,680
R01 · FY2021 · AG
Aging and the mitochondrial response to exercise training, measured by noninvasive 31P magnetic resonance spectroscopy - sIRB supplment$32,500
R01 · FY2021 · AG · contact PI
Reducing African Americans' Alzheimer's Disease Risk Through Exercise-MCI Cohort (RAATE-MCI)$968,867
R01 · FY2020 · AG
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study$722,108
R01 · FY2020 · AG
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)$716,897
R01 · FY2020 · AG
Aging and the mitochondrial response to exercise training, measured by noninvasive 31P magnetic resonance spectroscopy$667,911
R01 · FY2020 · AG · contact PI
Administrative Supplement Request to Lifespan Cardiovascular Risk Exposures and Alzheimer-related Brain Health$369,440
RF1 · FY2020 · AG
Supplemental Funding Request for RF1 AG062309 Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study$310,085
R01 · FY2020 · AG
Aging and the mitochondrial response to exercise training, measured by noninvasive 31P magnetic resonance spectroscopy$32,500
R01 · FY2020 · AG · contact PI
Lifespan Cardiovascular Risk Exposures and Alzheimer-related brain health: Bogalusa Heart Study$3,599,769
RF1 · FY2019 · AG
Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study$721,323
R01 · FY2019 · AG
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)$715,602
R01 · FY2019 · AG
"MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies"$103,588
K01 · FY2012 · AG · contact PI
"MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies"$103,588
K01 · FY2011 · AG · contact PI
"MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies"$97,007
K01 · FY2010 · AG · contact PI
"MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies"$99,130
K01 · FY2009 · AG · contact PI
"MR Morphometrics and Cognitive Decline Rate in Large-Scale Aging Studies"$92,176
K01 · FY2008 · AG · contact PI